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Sunday, February 3, 2013 155ademonstrated that a restrictive proteolytic truncation of the N-terminal tension
of cardiac TnI naturally occurs in normal hearts and is up-regulated in cardiac
adaptation to hemodynamic stress or ß-adrenergic deficiency. The N-terminal
truncated cardiac TnI (cTnI-ND) alters the conformation of the core structure
of cardiac TnI, similarly to that produced with PKA phosphorylation. At organ
level, cTnI-ND enhanced ventricular diastolic function. To investigate the
functional effect of cTnI-ND at the cellular level avoiding the influence of ex-
tracellular matrix, young adult (2-3 months old) cardiomyocytes were isolated
from wild type and cTnI-ND transgenic mouse hearts and studied for morphol-
ogy, sarcomere length, shortening amplitude and velocity, and intracellular
calcium transient. Paced contractions and calcium transient were examined
using an IonOptix cell imaging system on freshly isolated cardiomyocytes in
healthy condition as shown by a positive frequency response. cTnI-ND
cardiomyocytes exhibited no difference from wild type cells in length, width
and sarcomere length, indicating an absence of pathological remodeling.
cTnI-ND cardiomyocytes exhibited larger shortening amplitude and higher
shortening/re-lengthening velocities than that of wild type cells. The amplitude
of Ca2þ transient was also higher and the durations of Ca2þ rising and decaying
were shorter in cTnI-ND myocytes vs. the control. Isoproterenol treatment sig-
nificantly increased the amplitude of contractility and calcium transient of both
wild type and cTnI-ND cardiomyocytes and diminished their differences. The
non-additive effects of cTnI-ND and ß-adrenergic stimulation suggest that
cTnI-ND enhances cardiac muscle performance via the same mechanism as
that of PKA-catalyzed N-terminal phosphorylation of intact cTnI. The func-
tional effect of cTnI-ND demonstrates a posttranslational regulatory mecha-
nism to modulate cardiac muscle contractility in physiological adaptation
and heart failure.
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The C-terminal segment of troponin I (TnI) containing the last 27-33 amino
acids is highly conserved and critical for the inhibitory function of TnI. We re-
cently showed a Ca2þ-regulated interaction between this C-terminal segment of
TnI and tropomyosin (Zhang et al., FEBS J. 278:3348-59, 2011). Several mu-
tations in or near the C-terminal segment of cardiac TnI (K178E, R192H and
R204H) are found to cause restrictive cardiomyopathy in humans and con-
firmed in transgenic mice models. K179E presented a more severe phenotype
than that of R192H in transgenic mice with early lethality. Patients with cardiac
TnI-R204H mutation were presented with either hypertrophic or restrictive
cardiomyopathy. To understand the function of TnI C-terminal region in the
regulation of muscle contraction and in the pathogenesis of cardiomyopathy,
we constructed mouse cardiac TnI containing K179E, R193H or R205H muta-
tion. Using recombinant proteins, monoclonal antibody epitope analysis
demonstrated that R193H abolished a C-terminal structure highly conserved
in all TnI isoforms across vertebrate species, but did not alter calcium regulated
binding of TnI to tropomyosin in reconstituted troponin complex. R205H
resulted in a significant conformational change in the middle region troponin
C-binding helix of cardiac TnI. Mutations R193H and K179E had similar but
weaker effects. Protein binding assays showed that mutations R193H and
K179E slightly increased the binding affinity of cardiac TnI for troponin T
with statistic significance, whereas R205H drastically decreased the binding.
The binding affinity for troponin C was also very much decreased in the
R205H mutation. These results provided novel evidence for the critical func-
tion of the highly conserved C-terminal segment of TnI, in which mutations
may alter local and long-range effects on the function of the troponin complex
with major pathological impact.
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Phosphorylation of cardiac troponin I serines 43/45 (cTnISer43/45) by protein
kinase C (PKC) is associated with cardiac dysfunction, and yet there is dis-
agreement about the role this cluster plays in modulating contractile perfor-
mance. The present study evaluates the impact of phospho-null Ala
substitutions at Ser43/45 (cTnISer43/45Ala) on contractile performance in in-
tact myocytes. Viral-based gene transfer of cardiac troponin I (cTnI) or
cTnISer43/45Ala resulted in time-dependent increases in expression and 70-
80% of endogenous cTnI replaced within 4 days. Western analysis of intactand permeabilized myocytes along with immunohistochemistry showed each
exogenous cTnI was incorporated into the sarcomere within myocytes. In
contractile function studies, there were no differences in shortening and
re-lengthening for cTnI and cTnISer43/45Ala-expressing myocytes 2 days
after gene transfer. However, more extensive replacement with cTnISer43/
45Ala at 4 days diminished peak shortening amplitude and accelerated
re-lengthening measured as the time to re-lengthening at 75% (TTR75%). A de-
crease in myofilament Ca2þ sensitivity of tension also was observed in
permeabilized myocytes expressing cTnISer43/45Ala and is consistent with ac-
celerated re-lengthening observed in intact myocytes under basal conditions.
Phosphorylation of cTnI Ser23/24 and the Ca2þ transient were not changed
in these myocytes. These results demonstrate extensive sarcomere expression
of cTnISer43/45Ala directly modulates myofilament function under basal con-
ditions. In further work, the accelerated re-lengthening observed in control or
cTnI-expressing myocytes treated with the PKC agonist, endothelin-1 (ET,
10nM) was slowed in myocytes expressing cTnISer43/45Ala. This outcome
may indicate Ser43/45 is targeted for phosphorylation by ET-activated PKC
and/or influences transduction of this agonist-activated response.
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Perturbations in Protein kinase C (PKC) isoform expression and localization
have been reported in failing cardiomyocytes. Previous studies suggested
that PKC-mediated phosphorylation of cardiac troponin I (cTnI) underlies
myofilament dysfunction in cardiac disease. PKC phosphorylates cTnI at var-
ious sites; however, the functional effects of PKC-mediated cTnI phosphoryla-
tion at these different sites in human myocardium are unknown. In the present
study, we investigated the effects of cTnI phosphorylation at well-known PKC-
sites Ser42/44 and Thr143, and the recently identified PKC-site Ser199 on myo-
filament function in human failing cardiomyocytes.
Myofilament force development was measured at various [Ca2þ] and sarco-
mere lengths of 1.8 and 2.2 mm in permeabilized end-stage failing cardiomyo-
cytes in which endogenous troponin complex was partially exchanged
(66.251.6%) with recombinant whole human troponin complexes. Site-
directed mutagenesis was used to replace the Ser/Thr of the PKC-sites by as-
partic acid (D) or alanine (A) to mimic phosphorylation and dephosphorylation,
respectively. In addition, wild-type troponin (Wt) was used as a control.
Myofilament Ca2þ-sensitivity (pCa50) was significantly reduced by pseudo-
phosphorylation of Ser42/44 (pCa50=5.3650.01), while an increase was
found with pseudophosphorylated Thr143 (pCa50=5.6850.02) and Ser199
(pCa50=5.7250.01) in comparison to Wt (pCa50=5.5950.02). Only at
the Ser42/44 sites, alanine mutations affected Ca2þ-sensitivity (pCa50 =
5.5050.02) compared to Wt. The length-dependent increase in myofilament
Ca2þ-sensitivity and maximal force was not significantly affected by pseudo-
phosphorylation of the different PKC sites.
These opposite site-specific effects suggest that the collective effect of various
PKC isoforms on myofilament Ca2þ-sensitivity depends on the degree at which
the different sites are phosphorylated.
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Recombinant human cardiac actin mutants E99K, A331P, and WT were ex-
pressed in baculovirus/insect cells and used to reconstitute the thin-filament
of bovine cardiac fibers, together with tropomyosin (Tm) and troponin (Tn). Ef-
fects of [Ca2þ], [ATP], [phosphate] and [ADP] on tension and its transients
were studied at 25C. After actin filament reconstitution, tension of WT actin
reconstituted fibers reached 0.7550.06 T0 (T0: tension of native fibers), which
is comparable to rabbit skeletal actin reconstituted fibers (0.7350.07 T0).
However, tension was less in E99K (0.6050.08 T0) and A331P (0.5550.03
T0). After Tm and Tn reconstitution, tension for E99K was 0.7650.01 T0,
and A331P 0.6550.02 T0, which were less than WT (0.8550.06 T0). E99K
increased pCa50 (5.7850.03) but decreased cooperativity (1.7850.18) com-
pared with WT (5.7050.03, 2.650.3, respectively). A331P decreased pCa50
